African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2184

Full Length Research Paper

Evaluation of in vitro antioxidant capacity and reducing potential of polyherbal drug Entoban

Sadia Shakeel*
  • Sadia Shakeel*
  • Dow College of Pharmacy, Dow University of Health Sciences, Karachi-75270 – Pakistan.
  • Google Scholar
Khan Usmanghani
  • Khan Usmanghani
  • Herbion Pakistan (Pvt.) Ltd., Korangi Industrial Area, Karachi-74900, Pakistan.
  • Google Scholar
Somia Gul
  • Somia Gul
  • Faculty of Pharmacy, Jinnah University for Women, Karachi-74600, Pakistan.
  • Google Scholar
Zeeshan Ahmed Sheikh
  • Zeeshan Ahmed Sheikh
  • Herbion Pakistan (Pvt.) Ltd., Korangi Industrial Area, Karachi-74900, Pakistan.
  • Google Scholar
Syed Faisal Zaidi
  • Syed Faisal Zaidi
  • Department of Basic Medical Sciences, College of Medicine, King Saud bin AbdulAziz University of Health Sciences, Jeddah, Kingdom of Saudi Arabia.
  • Google Scholar
Mehreen Lateef
  • Mehreen Lateef
  • Multi Disciplinary Research Laboratory (MDRL), Bahria University Medical and Dental College, Karachi-75500, Pakistan.
  • Google Scholar

  •  Received: 04 May 2015
  •  Accepted: 02 October 2015
  •  Published: 29 October 2015


Antioxidants are used as a persuasive remedial measure against overproduction of reactive oxygen species owing to their capacity to neutralize free radicals by oxidation. Immense interest has been observed in antioxidants of natural origin and their contribution in human health. The current investigation is undertaken to explore antioxidant capacity and reducing potential of Entoban syrup and capsules. In vitro antioxidant activity was evaluated by measuring the scavenging ability of syrup and capsules on free radical 2,2’-diphenyl-1-picryl hydrazyl (DPPH). Antiradical activity assay depends on the reduction of DPPH.  The reducing ability was determined by the conversion of ferric into ferrous state by antioxidant compounds. Results showed that both formulations of syrup and capsules have excellent antioxidant potential with 8.5 and 10.3 µg/ml IC50 values respectively while butylated hydroxyanisole (BHA), the standard have 5.6 µg/ml IC50 value. When formulations of syrup and capsules were compared at various concentrations (10, 50 and 100 µg/ml), reducing ability increased in a dose dependent manner just like DPPH for both formulations just like standard BHA indicting good reducing ability. In-vitro antioxidant analysis of the polyherbal drug revealed the presence of excellent antioxidant potential and reducing capability which increases in a dose dependent manner for both formulations. It might be helpful in preventing or slowing the progress of various oxidative stress- related diseases related to gastro intestinal tract.
Key words: Antioxidant capacity, reducing potential, Entoban.